YU34407B - Process for preparing a novel substituted benzylimidazolidinone - Google Patents

Process for preparing a novel substituted benzylimidazolidinone

Info

Publication number
YU34407B
YU34407B YU439/71A YU43971A YU34407B YU 34407 B YU34407 B YU 34407B YU 439/71 A YU439/71 A YU 439/71A YU 43971 A YU43971 A YU 43971A YU 34407 B YU34407 B YU 34407B
Authority
YU
Yugoslavia
Prior art keywords
benzylimidazolidinone
preparing
novel substituted
substituted
novel
Prior art date
Application number
YU439/71A
Other languages
English (en)
Other versions
YU43971A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of YU43971A publication Critical patent/YU43971A/xx
Publication of YU34407B publication Critical patent/YU34407B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
YU439/71A 1970-02-24 1971-02-23 Process for preparing a novel substituted benzylimidazolidinone YU34407B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1376970A 1970-02-24 1970-02-24

Publications (2)

Publication Number Publication Date
YU43971A YU43971A (en) 1978-12-31
YU34407B true YU34407B (en) 1979-07-10

Family

ID=21761656

Family Applications (1)

Application Number Title Priority Date Filing Date
YU439/71A YU34407B (en) 1970-02-24 1971-02-23 Process for preparing a novel substituted benzylimidazolidinone

Country Status (18)

Country Link
US (1) US3636039A (da)
JP (1) JPS5421338B1 (da)
BE (1) BE763298A (da)
BR (1) BR7101125D0 (da)
CA (1) CA967163A (da)
CH (2) CH567483A5 (da)
DE (1) DE2108438A1 (da)
DK (2) DK134601B (da)
FI (1) FI54919C (da)
FR (1) FR2081537B1 (da)
GB (1) GB1292768A (da)
IE (1) IE35283B1 (da)
IL (1) IL36237A (da)
NL (1) NL171446C (da)
NO (1) NO130680C (da)
SE (1) SE369190B (da)
YU (1) YU34407B (da)
ZA (1) ZA711077B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones
US3966758A (en) * 1975-06-16 1976-06-29 Morton-Norwich Products, Inc. Anti-inflammatory 1-(substituted benzyl)-2-imidazolidinones
US4063022A (en) * 1976-11-22 1977-12-13 Morton-Norwich Products, Inc. Antisecretory 2-imidazolidinones
HU179019B (en) * 1978-11-01 1982-08-28 Gyogyszekutato Intezet Process for preparing 4-//3,4-dialkoxy-phenyl/-alkyl/- 2imidazolidinone derivatives
CA1188616A (en) * 1981-06-11 1985-06-11 Hoffmann-La Roche Limited Pharmaceutical preparations
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
JP2001523213A (ja) * 1994-12-13 2001-11-20 ユーロ−セルティーク，エス．エイ． 三置換チオキサンチン類
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
US6555572B2 (en) 2000-03-16 2003-04-29 Inflazyme Pharmaceuticals Ltd. Benzylated PDE4 inhibitors
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃアゴニストの調製方法
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH518285A (de) * 1968-05-01 1972-01-31 Hoffmann La Roche Verfahren zur Herstellung von neuen substituierten Benzylimidazolidinonen

Also Published As

Publication number Publication date
IL36237A (en) 1974-11-29
FI54919C (fi) 1979-04-10
DE2108438A1 (de) 1971-09-09
BE763298A (fr) 1971-08-23
DK570075A (da) 1975-12-15
IL36237A0 (en) 1971-04-28
FR2081537A1 (da) 1971-12-03
DK134601C (da) 1977-05-16
GB1292768A (en) 1972-10-11
CH567482A5 (da) 1975-10-15
CA967163A (en) 1975-05-06
NO130680C (da) 1975-01-22
CH567483A5 (da) 1975-10-15
DK134601B (da) 1976-12-06
ZA711077B (en) 1971-10-27
NL7102324A (da) 1971-08-26
NL171446B (nl) 1982-11-01
IE35283L (en) 1971-08-24
IE35283B1 (en) 1976-01-07
SE369190B (da) 1974-08-12
FR2081537B1 (da) 1974-08-23
US3636039A (en) 1972-01-18
NO130680B (da) 1974-10-14
NL171446C (nl) 1983-04-05
BR7101125D0 (pt) 1973-04-26
JPS5421338B1 (da) 1979-07-30
FI54919B (fi) 1978-12-29
YU43971A (en) 1978-12-31
DE2108438C2 (da) 1987-02-05

Similar Documents

Publication Publication Date Title
YU34407B (en) Process for preparing a novel substituted benzylimidazolidinone
YU208471A (en) Process for preparing novel oxazolo-or thiazoloazepine derivatives
YU34671B (en) Process for preparing novel substituted phenyl-2-pyrrolidones
JPS53149921A (en) Process for preparing diesterdiamide
YU196072A (en) Process for preparing a novel primidinyl-pyrazolinone derivative
YU122971A (en) Process for preparing compounds
YU211971A (en) Process for preparing novel thio-piperidine derivatives
CS194665B2 (en) Process for preparing new phenylaminoalkanes
YU35774B (en) Process for preparing erythromycylamine compounds
ZA711022B (en) Process for preparing novel substituted quinoxaline-di-oxides
YU70171A (en) Process for preparing n-methylazoles
YU35773B (en) Process for preparing erythromycylamine compounds
IL36143A0 (en) Process for preparing n-alkyl-dimethylamines
JPS53116397A (en) Process for preparing imidazoleeribocyclophosphate
IL37827A (en) Process for preparing substituted cobamides
YU260071A (en) Process for preparing novel quinazolone-diurethanes
YU268371A (en) Process for preparing delta-substituted 2-aminomethylbenzylalcohols
ZA717077B (en) Process for preparing osaziridines
YU34786B (en) Process for preparing des-phenylalanine-bi-insulin
YU52071A (en) Process for preparing 9delta-chloro-11b-hydroxy-3-keto-4-pregnenes
ZA713885B (en) Process for preparing triketoimidazolidines
YU166071A (en) Process for preparing novel substituted phenyl-thiol-carbamates
YU34419B (en) Process for preparing thiadiazolyl-carbamides
YU172270A (en) Process for preparing a novel penicillin
YU34048B (en) Process for preparing a novel penicillin